Kenvue (KVUE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Core Insights - Kenvue reported revenue of $3.66 billion for the quarter ended December 2024, a slight decline of 0.1% year-over-year, and EPS of $0.26, down from $0.31 in the same quarter last year [1] - The revenue fell short of the Zacks Consensus Estimate of $3.77 billion by 2.94%, while the EPS met the consensus estimate [1] Financial Performance Metrics - Net Sales in Self Care reached $1.57 billion, slightly below the estimated $1.59 billion, reflecting a year-over-year increase of 2.1% [4] - Net Sales in Essential Health totaled $1.08 billion, missing the average estimate of $1.17 billion, representing a decline of 4.1% year-over-year [4] - Net Sales in Skin Health and Beauty amounted to $1.01 billion, slightly below the estimated $1.02 billion, with a year-over-year increase of 1% [4] - Adjusted Operating Income for Self Care was $481 million, below the estimate of $593.82 million [4] - Adjusted Operating Income for Essential Health was $248 million, significantly above the estimate of $81.11 million [4] - Adjusted Operating Income for Skin Health and Beauty was $105 million, falling short of the estimated $190.78 million [4] Stock Performance - Kenvue's shares have returned -1.7% over the past month, contrasting with the Zacks S&P 500 composite's increase of 2.1% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]